<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Neurol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Neurol Sci</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>Neurological Sciences</journal-title></journal-title-group><issn pub-type="ppub">1590-1874</issn><issn pub-type="epub">1590-3478</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10858087</article-id><article-id pub-id-type="pmcid-ver">PMC10858087.1</article-id><article-id pub-id-type="pmcaid">10858087</article-id><article-id pub-id-type="pmcaiid">10858087</article-id><article-id pub-id-type="pmid">37718349</article-id><article-id pub-id-type="doi">10.1007/s10072-023-07026-x</article-id><article-id pub-id-type="publisher-id">7026</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Do stroke services still show sex differences? A multicenter study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Nahas</surname><given-names initials="NE">Nevine El</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6154-6806</contrib-id><name name-style="western"><surname>Shokri</surname><given-names initials="H">Hossam</given-names></name><address><email>hossam.shokri@med.asu.edu.eg</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Roushdy</surname><given-names initials="T">Tamer</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dawood</surname><given-names initials="N">Noha</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zaki</surname><given-names initials="A">Amr</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Farhoudi</surname><given-names initials="M">Mehdi</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hokmabadi</surname><given-names initials="ES">Elyar Sadeghi</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Al Hashmi</surname><given-names initials="A">Amal</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brola</surname><given-names initials="W">Waldemar</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kosno</surname><given-names initials="K">Krystian</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Falup-Pecurariu</surname><given-names initials="C">Cristian</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ciopleias</surname><given-names initials="B">Bogdan</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Montaner</surname><given-names initials="J">Joan</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>P&#233;rez-S&#225;nchez</surname><given-names initials="S">Soledad</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mittal</surname><given-names initials="M">Manoj</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dowd</surname><given-names initials="K">Kandis</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Banke</surname><given-names initials="A">Annie</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vigilante</surname><given-names initials="N">Nicholas</given-names></name><xref ref-type="aff" rid="Aff11">11</xref><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Siegler</surname><given-names initials="J">James</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ozdemir</surname><given-names initials="AO">Atilla Ozcan</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Aykac</surname><given-names initials="O">Ozlem</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kocabas</surname><given-names initials="ZU">Zehra Uysal</given-names></name><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Melgarejo</surname><given-names initials="D">Donoband</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cardozo</surname><given-names initials="A">Analia</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Peralta</surname><given-names initials="L">Lorena</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Aref</surname><given-names initials="H">Hany</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Caso</surname><given-names initials="V">Valeria</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cb9w016</institution-id><institution-id institution-id-type="GRID">grid.7269.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0621 1570</institution-id><institution>Neurology Department, Faculty of Medicine, </institution><institution>Ain Shams University, </institution></institution-wrap>Cairo, Egypt </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04krpx645</institution-id><institution-id institution-id-type="GRID">grid.412888.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 2174 8913</institution-id><institution>Neurosciences Research Center, </institution><institution>Tabriz University of Medical Sciences, </institution></institution-wrap>Tabriz, Iran </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02v6ptf51</institution-id><institution-id institution-id-type="GRID">grid.415206.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 0621 7948</institution-id><institution>Central Stroke Unit, Neuroscience Directorate, </institution><institution>Khoula Hospital, </institution></institution-wrap>Muscat, Oman </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00krbh354</institution-id><institution-id institution-id-type="GRID">grid.411821.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 2292 9126</institution-id><institution>Department of Neurology, Specialist Hospital Konskie, Collegium Medicum, </institution><institution>Jan Kochanowski University, </institution></institution-wrap>Kielce, Poland </aff><aff id="Aff5"><label>5</label>Department of Neurology, Specialist Hospital, Konskie, Poland </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.5120.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2159 8361</institution-id><institution>Department of Neurology, Faculty of Medicine, </institution><institution>University Transilvania, </institution></institution-wrap>Brasov, Romania </aff><aff id="Aff7"><label>7</label>Department of Neurology, County Clinic Hospital, Brasov, Romania </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.9224.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2168 1229</institution-id><institution>Neurovascular Research Group, Biomedicine Institute of Seville, </institution><institution>IBiS/Hospital Virgen del Roc&#237;o/CSIC/University of Seville, </institution></institution-wrap>Seville, Spain </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/016p83279</institution-id><institution-id institution-id-type="GRID">grid.411375.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1768 164X</institution-id><institution>Department of Neurology, </institution><institution>Hospital Universitario Virgen Macarena, </institution></institution-wrap>Seville, Spain </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03zk9v026</institution-id><institution-id institution-id-type="GRID">grid.416763.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0451 0411</institution-id><institution>Stroke and Neurocritical Care, </institution><institution>Sutter Medical Center, </institution></institution-wrap>Sacramento, CA USA </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/007evha27</institution-id><institution-id institution-id-type="GRID">grid.411897.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 6070 865X</institution-id><institution>Cooper Medical School of Rowan University, </institution></institution-wrap>Camden, NJ USA </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.411896.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0384 9827</institution-id><institution>Cooper Neurological Institute, </institution><institution>Cooper University Hospital, </institution></institution-wrap>Camden, NJ USA </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.164274.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0596 2460</institution-id><institution>Faculty of Medicine, </institution><institution>Eskisehir Osmangazi University, </institution></institution-wrap>Eskisehir, Turkey </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/048b0cg51</institution-id><institution-id institution-id-type="GRID">grid.512913.d</institution-id><institution>Stroke Unit, </institution><institution>Instituto de Previsi&#243;n Social Central Hospital, </institution></institution-wrap>Asunci&#243;n, Paraguay </aff><aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00x27da85</institution-id><institution-id institution-id-type="GRID">grid.9027.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 3630</institution-id><institution>Stroke Unit, Santa Maria Della Misericordia Hospital, </institution><institution>University of Perugia, </institution></institution-wrap>Perugia, Italy </aff></contrib-group><pub-date pub-type="epub"><day>18</day><month>9</month><year>2023</year></pub-date><pub-date pub-type="ppub"><year>2024</year></pub-date><volume>45</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">455620</issue-id><fpage>1097</fpage><lpage>1108</lpage><history><date date-type="received"><day>4</day><month>7</month><year>2023</year></date><date date-type="accepted"><day>15</day><month>8</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>18</day><month>09</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>11</day><month>02</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-02-11 00:25:09.943"><day>11</day><month>02</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10072_2023_Article_7026.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">The issue of sex differences in stroke has gained concern in the past few years. However, multicenter studies are still required in this field. This study explores sex variation in a large number of patients and compares stroke characteristics among women in different age groups and across different countries.</p></sec><sec><title>Methods</title><p id="Par2">This multicenter retrospective cross-sectional study aimed to compare sexes regarding risk factors, stroke severity, quality of services, and stroke outcome. Moreover, conventional risk factors in women according to age groups and among different countries were studied.</p></sec><sec><title>Results</title><p id="Par3">Eighteen thousand six hundred fifty-nine patients from 9 countries spanning 4 continents were studied. The number of women was significantly lower than men, with older age, more prevalence of AF, hypertension, and dyslipidemia. Ischemic stroke was more severe in women, with worse outcomes among women (<italic toggle="yes">p</italic>:&#8201;&lt;&#8201;0.0001), although the time to treatment was shorter. Bridging that was more frequent in women (<italic toggle="yes">p</italic>:0.002). Analyzing only women: ischemic stroke was more frequent among the older, while hemorrhage and TIA prevailed in the younger and stroke of undetermined etiology. Comparison between countries showed differences in age, risk factors, type of stroke, and management.</p></sec><sec><title>Conclusion</title><p id="Par4">We observed sex differences in risk factors, stroke severity, and outcome in our population. However, access to revascularization was in favor of women.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Stroke services</kwd><kwd>Stroke</kwd><kwd>Women</kwd><kwd>Sex differences</kwd><kwd>Stroke characteristics</kwd><kwd>Stroke outcome</kwd></kwd-group><funding-group><award-group><funding-source><institution>Ain Shams University</institution></funding-source></award-group><open-access><p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Fondazione Societ&#224; Italiana di Neurologia 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">The incidence of ischemic stroke is increasing with age, especially among women. It ranges from 41.5&#8211;70.5/100 thousand in western countries to 131&#8211;151.5/100 thousand in eastern countries [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par6">Since 2001, the Institute of Medicine has highlighted the importance of studying sex differences in diseases and its impact on outcome [<xref ref-type="bibr" rid="CR2">2</xref>].</p><p id="Par7">Exploring such differences can promote more precise management protocols in acute and chronic stroke settings. Furthermore, data about sex variability concerning the delay of onset to door and door to treatment times still need unravelling, as this information can impact equity of stroke services and, consequently, stroke outcome [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par8">And despite that several articles have demonstrated a minimal sex difference in revascularization therapy yet, this might still negatively influence disease outcomes in women [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par9">Moreover, even fewer studies have touched on the issue of stroke in women in the context of an epidemiological study among different geographical regions [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par10">Furthermore, the variance in ethnicity, culture, nutrition, and health habits among populations can influence sex-related health services. Thus, stroke risk factors in women need to be investigated in various regions of the world.</p><p id="Par11">Accordingly, the current study was conducted to compare sex differences relevant to stroke risk factors, quality of management, and outcome of acute ischemic stroke (AIS). In addition, we were also interested in exploring these sex differences among various countries.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par12">This is a multicentric, observational, cross-sectional, retrospective study done by analyzing stroke units&#8217; databases of participating countries.</p><p id="Par13">Representatives of stroke units/centers who previously participated and co-authored an earlier study [<xref ref-type="bibr" rid="CR7">7</xref>] were contacted through email and invited to share their stroke units&#8217; data for analysis. Time period was specified in the study protocol sent to all participating centers as &#8220;The past 5&#160;years from January 2017 till January 2022.&#8221;</p><p id="Par14">A total of 9 centers, representing 9 different countries and 4 continents, participated, including Egypt, Iran, Oman, Poland, Romania, Spain, the USA, Turkey, and Paraguay. All types of stroke were studied (acute ischemic stroke (AIS), hemorrhagic, transient ischemic attack (TIA), and subarachnoid hemorrhage). The study population was evaluated for risk factors, stroke subtypes, stroke severity according to the National Institutes of Health Stroke Scale (NIHSS), and acute stroke management based on current international guidelines: intravenous thrombolysis (IVT), thrombectomy (MT), or bridging between men and women. The outcome was measured by the modified Rankin scale (mRS), defining favorable outcome as mRS&#8201;&lt;&#8201;2.</p><p id="Par15">Women were further divided into the childbearing period (CB) (18&#8211;45&#160;years), premenopausal (PM) (46&#8211;60&#160;years), and menopausal (M) (&gt;&#8201;60&#160;years). A comparison was made between different age categories regarding types of stroke, TOAST classification of ischemic stroke, management, and outcome on discharge and at 3&#160;months follow-up.</p><p id="Par16">Finally, a comparison among countries was made for age, risk factors, type of stroke, and management.</p><sec id="Sec3"><title>Statistics</title><p id="Par17">Statistical analysis was done using SPSS version 19<sup>th</sup> (SPSS Inc., Chicago). To test for normality of continuous data distribution, the Shapiro-Wilks test was used. Mean and standard deviation were used for normally distributed data, while median and interquartile range (IQR) were used for shewed data. Categorical data were presented as frequencies. The Mann&#8211;Whitney test or Kruskal&#8211;Wallis test was used to compare not normally distributed continuous variables with nominal independent variables. The chi-square test was used for comparison of nominal data.</p></sec></sec><sec id="Sec4"><title>Results</title><sec id="Sec5"><title>Demographic data and clinical characteristics for both groups: (Table <xref rid="Tab1" ref-type="table">1</xref>)</title><table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Comparison of stroke demographics between both sexes</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Men<break/><italic toggle="yes">n</italic>&#8201;=&#8201;10,437 (55.9%)</th><th align="left" colspan="1" rowspan="1">Women<break/><italic toggle="yes">n</italic>&#8201;=&#8201;8222 (44.1%)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age*</td><td align="left" colspan="1" rowspan="1">65 (57&#8211;75)</td><td align="left" colspan="1" rowspan="1">69 (59&#8211;78)</td><td char="." align="char" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="4" rowspan="1">Age category</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; (0&#8211;45&#160;years) 8.5%</td><td align="left" colspan="1" rowspan="1">8.6%</td><td align="left" colspan="1" rowspan="1">8.4%</td><td char="." align="char" colspan="1" rowspan="1">0.6</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; (46&#8211;60&#160;years) 23.5%</td><td align="left" colspan="1" rowspan="1">26.6%</td><td align="left" colspan="1" rowspan="1">19.5%</td><td char="." align="char" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; (&gt;&#8201;60&#160;years) 68%</td><td align="left" colspan="1" rowspan="1">64.7%</td><td align="left" colspan="1" rowspan="1">72.1%</td><td char="." align="char" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Atrial fibrillation (admission/past history)</td><td align="left" colspan="1" rowspan="1">15.6%</td><td align="left" colspan="1" rowspan="1">20.4%</td><td char="." align="char" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Hypertension (admission/past history)</td><td align="left" colspan="1" rowspan="1">68.5%</td><td align="left" colspan="1" rowspan="1">74.9%</td><td char="." align="char" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes (admission/past history)</td><td align="left" colspan="1" rowspan="1">33.8%</td><td align="left" colspan="1" rowspan="1">33.7%</td><td char="." align="char" colspan="1" rowspan="1">0.9</td></tr><tr><td align="left" colspan="1" rowspan="1">Dyslipidemia (admission/past history)</td><td align="left" colspan="1" rowspan="1">21.7%</td><td align="left" colspan="1" rowspan="1">24.3%</td><td char="." align="char" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Current smoker</td><td align="left" colspan="1" rowspan="1">22.9%</td><td align="left" colspan="1" rowspan="1">8.7%</td><td char="." align="char" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Previous TIA or stroke</td><td align="left" colspan="1" rowspan="1">16.8%</td><td align="left" colspan="1" rowspan="1">17.3%</td><td char="." align="char" colspan="1" rowspan="1">0.33</td></tr><tr><td align="left" colspan="1" rowspan="1">Congestive heart failure</td><td align="left" colspan="1" rowspan="1">6.5%</td><td align="left" colspan="1" rowspan="1">6.9%</td><td char="." align="char" colspan="1" rowspan="1">0.38</td></tr><tr><td align="left" colspan="1" rowspan="1">Vascular disease</td><td align="left" colspan="1" rowspan="1">13.0%</td><td align="left" colspan="1" rowspan="1">11.8%</td><td char="." align="char" colspan="1" rowspan="1">
<bold>0.02</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">NIHSS admission*</td><td align="left" colspan="1" rowspan="1">8 (3&#8211;14)</td><td align="left" colspan="1" rowspan="1">9 (4&#8211;17)</td><td char="." align="char" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="4" rowspan="1">Type of stroke:</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Ischemic stroke</td><td align="left" colspan="1" rowspan="1">81.1%</td><td align="left" colspan="1" rowspan="1">79.9%</td><td char="." align="char" colspan="1" rowspan="1">
<bold>0.03</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Hemorrhagic stroke</td><td align="left" colspan="1" rowspan="1">14.2%</td><td align="left" colspan="1" rowspan="1">13.3%</td><td char="." align="char" colspan="1" rowspan="1">0.07</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; TIA</td><td align="left" colspan="1" rowspan="1">4%</td><td align="left" colspan="1" rowspan="1">6%</td><td char="." align="char" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Subarachnoid hemorrhage</td><td align="left" colspan="1" rowspan="1">0.7%</td><td align="left" colspan="1" rowspan="1">0.8%</td><td char="." align="char" colspan="1" rowspan="1">0.4</td></tr><tr><td align="left" colspan="4" rowspan="1">Acute intervention/treatment</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Conservative</td><td align="left" colspan="1" rowspan="1">81.5%</td><td align="left" colspan="1" rowspan="1">81.3%</td><td char="." align="char" colspan="1" rowspan="1">0.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; IVT</td><td align="left" colspan="1" rowspan="1">14.6%</td><td align="left" colspan="1" rowspan="1">14%</td><td char="." align="char" colspan="1" rowspan="1">0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; MT</td><td align="left" colspan="1" rowspan="1">2.9%</td><td align="left" colspan="1" rowspan="1">3.3%</td><td char="." align="char" colspan="1" rowspan="1">0.1</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; IVT, MT</td><td align="left" colspan="1" rowspan="1">1%</td><td align="left" colspan="1" rowspan="1">1.5%</td><td char="." align="char" colspan="1" rowspan="1">
<bold>0.002</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Onset to door (minutes)*</td><td align="left" colspan="1" rowspan="1">224 (90&#8211;720)</td><td align="left" colspan="1" rowspan="1">180 (83&#8211;600)</td><td char="." align="char" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Door to needle (minutes)*</td><td align="left" colspan="1" rowspan="1">46 (31&#8211;63)</td><td align="left" colspan="1" rowspan="1">45 (33&#8211;62)</td><td char="." align="char" colspan="1" rowspan="1">0.768</td></tr><tr><td align="left" colspan="1" rowspan="1">Duration of hospital stay (days) *</td><td align="left" colspan="1" rowspan="1">6 (3&#8211;10)</td><td align="left" colspan="1" rowspan="1">6 (3&#8211;11)</td><td char="." align="char" colspan="1" rowspan="1">0.185</td></tr><tr><td align="left" colspan="1" rowspan="1">mRS* discharge (favorable outcome)</td><td align="left" colspan="1" rowspan="1">29.2%</td><td align="left" colspan="1" rowspan="1">24.2%</td><td char="." align="char" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">mRS* 3&#160;months (favorable outcome)</td><td align="left" colspan="1" rowspan="1">39.2%</td><td align="left" colspan="1" rowspan="1">33.1%</td><td char="." align="char" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr></tbody></table><table-wrap-foot><p>*Median (IQR), <italic toggle="yes">TIA</italic> transient ischemic attack, <italic toggle="yes">NIHSS</italic> National Institutes of Health Stroke Scale, <italic toggle="yes">IVT</italic> intravenous thrombolysis, <italic toggle="yes">MT</italic> mechanical thrombectomy, <italic toggle="yes">mRS</italic> Modified Rankin Scale favorable outcome: (&lt;&#8201;2)</p><p>Bold values refer to statistically significant variables</p></table-wrap-foot></table-wrap><sec id="Sec6"><title>Risk factors</title><p id="Par18">A total of 18,659 patients were studied most of whom (68%) were in the age group&#8201;&gt;&#8201;60&#160;years. Women constituted 44.1% and had a significantly higher age than men (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001). The number of women was significantly lower than men in premenopausal age group, and higher in menopausal age group (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001).</p><p id="Par19">Regarding risk factors, women had more atrial fibrillation (AF), hypertension, and dyslipidemia (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001). At the same time, they were significantly lower in smoking (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001) and other vascular diseases (<italic toggle="yes">p</italic>&#8201;=&#8201;0.02).</p></sec><sec id="Sec7"><title>Type of stroke</title><p id="Par20">Ischemic strokes were more frequent in men than in women (<italic toggle="yes">p</italic>&#8201;=&#8201;0.03), while TIA was more in women (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.000). There was no difference in hemorrhagic between both sexes.</p></sec><sec id="Sec8"><title>Stroke severity and management</title><p id="Par21">NIHSS was significantly higher in women on admission. Moreover, the outcome, as measured by mRS, was less favorable in women at discharge and after 3&#160;months (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001). On the other hand, the type of acute management whether conservative or revascularization was similar, except for bridging therapy that was more frequently performed in women (<italic toggle="yes">p</italic>&#8201;=&#8201;0.002).</p><p id="Par22">Onset to door time (OTD) was significantly lower in women (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001), while door to needle (DTN) and hospital stay showed no difference between the sexes.</p></sec></sec><sec id="Sec9"><title>Comparison of stroke characteristics among women: (Table <xref rid="Tab2" ref-type="table">2</xref>)</title><table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Comparison of different age categories among women</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">CB</th><th align="left" colspan="1" rowspan="1">PM</th><th align="left" colspan="1" rowspan="1">M</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age</td><td align="left" colspan="1" rowspan="1">18&#8211;45&#160;years</td><td align="left" colspan="1" rowspan="1">46-60&#160;years</td><td align="left" colspan="1" rowspan="1">&#8201;&gt;&#8201;60&#160;years</td><td align="left" colspan="1" rowspan="1">CB:PM&#8201;=&#8201;&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">Frequency</td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#8201;=&#8201;688</td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#8201;=&#8201;1595</td><td align="left" colspan="1" rowspan="1"><italic toggle="yes">N</italic>&#8201;=&#8201;5891</td><td align="left" colspan="1" rowspan="1">PM:M&#8201;=&#8201;&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="1" rowspan="1">(%)</td><td align="left" colspan="1" rowspan="1">(8.4%)</td><td align="left" colspan="1" rowspan="1">(19.5%)</td><td align="left" colspan="1" rowspan="1">(72.1%)</td><td align="left" colspan="1" rowspan="1">CB:M&#8201;=&#8201;&#8201;&lt;&#8201;0.0001</td></tr><tr><td align="left" colspan="5" rowspan="1">
<italic toggle="yes">Type of stroke, %</italic>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Ischemic stroke</td><td align="left" colspan="1" rowspan="1">67.2%</td><td align="left" colspan="1" rowspan="1">69.6%</td><td align="left" colspan="1" rowspan="1">84%</td><td align="left" rowspan="4" colspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Hemorrhagic stroke</td><td align="left" colspan="1" rowspan="1">17.3%</td><td align="left" colspan="1" rowspan="1">16.3%</td><td align="left" colspan="1" rowspan="1">12.1%</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; TIA</td><td align="left" colspan="1" rowspan="1">12.6%</td><td align="left" colspan="1" rowspan="1">11.9%</td><td align="left" colspan="1" rowspan="1">3.75%</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Subarachnoid hemorrhage</td><td align="left" colspan="1" rowspan="1">2.9%</td><td align="left" colspan="1" rowspan="1">2.2%</td><td align="left" colspan="1" rowspan="1">0.2%</td></tr><tr><td align="left" colspan="1" rowspan="1">Post hoc</td><td align="left" colspan="4" rowspan="1">
<bold><italic toggle="yes">p</italic></bold>
<bold>-value</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">CB vs PM</td><td align="left" colspan="1" rowspan="1">CB vs M</td><td align="left" colspan="1" rowspan="1">PM vs M</td><td align="left" rowspan="5" colspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Ischemic stroke</td><td align="left" colspan="1" rowspan="1">0.2</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Hemorrhagic stroke</td><td align="left" colspan="1" rowspan="1">0.5</td><td align="left" colspan="1" rowspan="1">
<bold>0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; TIA</td><td align="left" colspan="1" rowspan="1">0.6</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Subarachnoid hemorrhage</td><td align="left" colspan="1" rowspan="1">0.2</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="5" rowspan="1">Type of ischemic stroke</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Small vessel stroke</td><td align="left" colspan="1" rowspan="1">10.2%</td><td align="left" colspan="1" rowspan="1">19.9%</td><td align="left" colspan="1" rowspan="1">14.65</td><td align="left" rowspan="5" colspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Large vessel disease with stenosis</td><td align="left" colspan="1" rowspan="1">19.4%</td><td align="left" colspan="1" rowspan="1">25.5%</td><td align="left" colspan="1" rowspan="1">23.2%</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Cardio-embolic</td><td align="left" colspan="1" rowspan="1">20.4%</td><td align="left" colspan="1" rowspan="1">21%</td><td align="left" colspan="1" rowspan="1">29.9%</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Undetermined etiology</td><td align="left" colspan="1" rowspan="1">18.1%</td><td align="left" colspan="1" rowspan="1">15.1%</td><td align="left" colspan="1" rowspan="1">12.8%</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Other determined etiology</td><td align="left" colspan="1" rowspan="1">31.9%</td><td align="left" colspan="1" rowspan="1">18.4%</td><td align="left" colspan="1" rowspan="1">19.5%</td></tr><tr><td align="left" colspan="1" rowspan="1">Post hoc</td><td align="left" colspan="4" rowspan="1">
<bold><italic toggle="yes">p</italic></bold>
<bold>-value</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">CB vs M</td><td align="left" colspan="1" rowspan="1">M vs PM</td><td align="left" colspan="1" rowspan="1">CB vs PM</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Small vessel/lacunar</td><td align="left" colspan="1" rowspan="1">
<bold>0.001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" rowspan="5" colspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Large vessel disease with stenosis</td><td align="left" colspan="1" rowspan="1">
<bold>0.02</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>0.05</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>0.001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Cardio-embolic</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">0.7</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Undetermined etiology</td><td align="left" colspan="1" rowspan="1">
<bold>0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>0.01</bold>
</td><td align="left" colspan="1" rowspan="1">0.07</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Other determined etiology</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">0.3</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="5" rowspan="1">Acute intervention treatment</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Conservative</td><td align="left" colspan="1" rowspan="1">83.8%</td><td align="left" colspan="1" rowspan="1">82.9%</td><td align="left" colspan="1" rowspan="1">80.5%</td><td align="left" rowspan="4" colspan="1">0.065</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; IVT</td><td align="left" colspan="1" rowspan="1">12.9%</td><td align="left" colspan="1" rowspan="1">13.2%</td><td align="left" colspan="1" rowspan="1">14.3%</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; MT</td><td align="left" colspan="1" rowspan="1">2.1%</td><td align="left" colspan="1" rowspan="1">2.5%</td><td align="left" colspan="1" rowspan="1">3.6%</td></tr><tr><td align="left" colspan="1" rowspan="1">&#160; IVT and MT</td><td align="left" colspan="1" rowspan="1">1.2%</td><td align="left" colspan="1" rowspan="1">1.3%</td><td align="left" colspan="1" rowspan="1">1.6%</td></tr><tr><td align="left" colspan="1" rowspan="1">Post hoc</td><td align="left" colspan="4" rowspan="1"><italic toggle="yes">p</italic>-value</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">CB vs M</td><td align="left" colspan="1" rowspan="1">M vs PM</td><td align="left" colspan="1" rowspan="1">CB vs PM</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160; Conservative</td><td align="left" colspan="1" rowspan="1">
<bold>0.03</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>0.03</bold>
</td><td align="left" colspan="1" rowspan="1">0.6</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160; IVT</td><td align="left" colspan="1" rowspan="1">0.3</td><td align="left" colspan="1" rowspan="1">0.2</td><td align="left" colspan="1" rowspan="1">0.8</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160; MT</td><td align="left" colspan="1" rowspan="1">
<bold>0.04</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>0.03</bold>
</td><td align="left" colspan="1" rowspan="1">0.5</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#160; IVT and MT</td><td align="left" colspan="1" rowspan="1">0.4</td><td align="left" colspan="1" rowspan="1">0.3</td><td align="left" colspan="1" rowspan="1">0.8</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Onset to needle (minutes)*</td><td align="left" colspan="1" rowspan="1">152 (115&#8211;190)</td><td align="left" colspan="1" rowspan="1">150 (109&#8211;195)</td><td align="left" colspan="1" rowspan="1">146 (104&#8211;188)</td><td align="left" colspan="1" rowspan="1">0.533</td></tr><tr><td align="left" colspan="1" rowspan="1">Door to needle (minutes)*</td><td align="left" colspan="1" rowspan="1">46 (30.5&#8211;85)</td><td align="left" colspan="1" rowspan="1">46 (35&#8211;61)</td><td align="left" colspan="1" rowspan="1">45 (33&#8211;62)</td><td align="left" colspan="1" rowspan="1">0.776</td></tr><tr><td align="left" colspan="1" rowspan="1">NIHSS admission</td><td align="left" colspan="1" rowspan="1">6 (2&#8211;13)</td><td align="left" colspan="1" rowspan="1">7 (3&#8211;15)</td><td align="left" colspan="1" rowspan="1">10 (4&#8211;18)</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>mRS discharge</p><p>(&lt;&#8201;2)</p></td><td align="left" colspan="1" rowspan="1">43.5%</td><td align="left" colspan="1" rowspan="1">33.6%</td><td align="left" colspan="1" rowspan="1">19.9%</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Post hoc</td><td align="left" colspan="1" rowspan="1">CB vs M</td><td align="left" colspan="1" rowspan="1">M vs PM</td><td align="left" colspan="1" rowspan="1">CB vs PM</td><td align="left" rowspan="2" colspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.00001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>mRS 3&#160;months</p><p>(&lt;&#8201;2)</p></td><td align="left" colspan="1" rowspan="1">58.5%</td><td align="left" colspan="1" rowspan="1">46.1%</td><td align="left" colspan="1" rowspan="1">26.5%</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Post hoc</td><td align="left" colspan="1" rowspan="1">CB vs M</td><td align="left" colspan="1" rowspan="1">M vs PM</td><td align="left" colspan="1" rowspan="1">CB vs PM</td><td align="left" rowspan="2" colspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr></tbody></table><table-wrap-foot><p>*Median (IQR), <italic toggle="yes">CB</italic> childbearing (18&#8211;45&#160;years), <italic toggle="yes">PM</italic> peri-menopause (46&#8211;60&#160;years), <italic toggle="yes">M</italic> menopausal (&gt;&#8201;60&#160;years), <italic toggle="yes">TIA</italic> transient ischemic attacks, <italic toggle="yes">IVT</italic> intravenous thrombolysis, <italic toggle="yes">MT</italic> mechanical thrombectomy, <italic toggle="yes">mRS</italic> Modified Rankin Scale favorable outcome: (&#8804;&#8201;2)</p><p>Bold values refer to statistically significant variables</p></table-wrap-foot></table-wrap><p id="Par23">Women tend to be significantly older (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001). Ischemic stroke was significantly higher among the older age group (post hoc analysis: menopausal group significantly more than the two younger age groups). On the contrary, hemorrhagic stroke, subarachnoid hemorrhage, and TIA were significantly higher in younger groups (post hoc analysis: the non-significant difference between CB and PM, and significant difference between both groups and M group).</p><p id="Par24">According to TOAST classification, small vessel stroke and large vessel stroke were higher in the PM group (post hoc analysis: significantly higher incidence in PM compared to the other two groups and higher in M compared to CB group). Cardio-embolic stroke was significantly higher in M group as compared to the 2 other younger groups, while there was no difference between CB and PM groups. Stroke of undetermined etiology was higher in younger age (CB) (post hoc analysis: significantly less in M compared to the other two groups). Stroke of other determined etiology was significantly more in CB age group as compared to the other two groups.</p><p id="Par25">Onset to needle and door to needle times showed no disparity among age groups. There was a marginal difference in favor of CB and PM groups compared to M group for conservative management (<italic toggle="yes">p</italic>&#8201;=&#8201;0.03), marginal difference in favor of M group compared with the two younger groups for MT (<italic toggle="yes">p</italic>&#8201;=&#8201;0.04, 0.03), and no difference regarding IVT.</p><p id="Par26">And NIHSS on admission was significantly higher in M group (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), whereas favorable outcome on discharge and at 3&#160;months was more frequently reported in younger age groups, being more significantly in CB compared to both PM and M and in PM compared to M (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.0001).</p></sec><sec id="Sec10"><title>Risk Factors according to sex among participating countries: (Table <xref rid="Tab3" ref-type="table">3</xref>)</title><p id="Par27"><table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Comparison of risk factors according to sex among the participating countries</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="MO1" orientation="portrait" xlink:href="10072_2023_7026_Tab3a_HTML.jpg"/><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="MO2" orientation="portrait" xlink:href="10072_2023_7026_Tab3b_HTML.jpg"/><table-wrap-foot><p>* Median (IQR), CB: childbearing (18-45y), PM: peri-menopause (46-60y), M: menopausal (&gt;60y),</p></table-wrap-foot></table-wrap>The median age in women was lower in both Egypt and Oman as compared to all other countries, and this comes in the context of a younger age of men, as well. It is also notable that the frequency of patients in the 2 younger age groups was higher in these 2 countries (37.2% and 50% respectively) compared to less than 30% in other countries.</p><p id="Par28">AF was significantly more reported among women in Egypt, Iran, Poland, Spain, and Turkey. Hypertension was more reported in women in Egypt, Iran, Spain, and Turkey, and more in men in Poland.</p><p id="Par29">Diabetes was more frequent in women in Iran and Turkey, and more in men in the USA. Dyslipidemia was significantly more frequent in women in Iran only. Smoking was more frequent in men in Egypt, Iran, Spain, USA, Turkey, and Paraguay.</p><p id="Par30">Previous stroke and congestive heart failure showed non-significant difference among both sexes in all countries. And other vascular diseases were more in men only in Egypt.</p></sec><sec id="Sec11"><title>Comparison of stroke severity, type, intervention, and outcome among the participating countries: (Tables <xref rid="Tab4" ref-type="table">4</xref> and <xref rid="Tab5" ref-type="table">5</xref>)</title><table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Comparison of stroke severity, type, and intervention among the participating countries</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="left" rowspan="2" colspan="1">Sex/No</th><th align="left" rowspan="2" colspan="1">NIHSS admission*</th><th align="left" colspan="4" rowspan="1">
<italic toggle="yes">Type of stroke</italic>
</th><th align="left" colspan="4" rowspan="1">
<italic toggle="yes">Acute management</italic>
</th><th align="left" rowspan="2" colspan="1">Onset to needle (minutes)*</th><th align="left" rowspan="2" colspan="1">Door to needle (minutes)*</th></tr><tr><th align="left" colspan="1" rowspan="1">Ischemic stroke</th><th align="left" colspan="1" rowspan="1">Hemorrhagic stroke</th><th align="left" colspan="1" rowspan="1">TIA</th><th align="left" colspan="1" rowspan="1">Subarachnoid hemorrhage</th><th align="left" colspan="1" rowspan="1">Conservative</th><th align="left" colspan="1" rowspan="1">IVT</th><th align="left" colspan="1" rowspan="1">MT</th><th align="left" colspan="1" rowspan="1">IVT, MT</th></tr></thead><tbody><tr><td align="left" rowspan="4" colspan="1">Egypt</td><td align="left" colspan="1" rowspan="1"><p>Men</p><p>(2807)</p></td><td align="left" colspan="1" rowspan="1"><p>6</p><p>(3&#8211;10)</p></td><td align="left" colspan="1" rowspan="1">86.6%</td><td align="left" colspan="1" rowspan="1">7.7%</td><td align="left" colspan="1" rowspan="1">2.4%</td><td align="left" colspan="1" rowspan="1">3.3%</td><td align="left" colspan="1" rowspan="1">82%</td><td align="left" colspan="1" rowspan="1">16.8%</td><td align="left" colspan="1" rowspan="1">1%</td><td align="left" colspan="1" rowspan="1">0.2%</td><td align="left" colspan="1" rowspan="1">178 (120&#8211;210)</td><td align="left" colspan="1" rowspan="1">45 (30&#8211;60)</td></tr><tr><td align="left" rowspan="2" colspan="1"><p>Women</p><p>(1813)</p></td><td align="left" rowspan="2" colspan="1"><p>7</p><p>(4&#8211;12)</p></td><td align="left" rowspan="2" colspan="1">85.6%</td><td align="left" rowspan="2" colspan="1">7.1%</td><td align="left" rowspan="2" colspan="1">2.4%</td><td align="left" rowspan="2" colspan="1">5%</td><td align="left" colspan="1" rowspan="1">82.8%</td><td align="left" colspan="1" rowspan="1">15.2%</td><td align="left" colspan="1" rowspan="1">1.2%</td><td align="left" colspan="1" rowspan="1">0.8%</td><td align="left" rowspan="2" colspan="1">160 (120&#8211;210)</td><td align="left" rowspan="2" colspan="1">40 (30&#8211;60)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">P:0.4</italic>
</td><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">P:0.1</italic>
</td><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">P:0.5</italic>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">P:0.002</italic></bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="4" rowspan="1">0.12</td><td align="left" colspan="4" rowspan="1">
<bold>0.008</bold>
</td><td align="left" colspan="1" rowspan="1">0.2</td><td align="left" colspan="1" rowspan="1">0.2</td></tr><tr><td align="left" rowspan="4" colspan="1">Iran</td><td align="left" colspan="1" rowspan="1"><p>Men</p><p>(3192)</p></td><td align="left" colspan="1" rowspan="1"><p>13</p><p>(6.3&#8211;22)</p></td><td align="left" colspan="1" rowspan="1">67.1%</td><td align="left" colspan="1" rowspan="1">24%</td><td align="left" colspan="1" rowspan="1">8.9%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">86.6%</td><td align="left" colspan="1" rowspan="1">13.3%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">0.1%</td><td align="left" colspan="1" rowspan="1">150 (115&#8211;195)</td><td align="left" colspan="1" rowspan="1">45 (33&#8211;64)</td></tr><tr><td align="left" rowspan="2" colspan="1"><p>Women</p><p>(2793)</p></td><td align="left" rowspan="2" colspan="1"><p>15</p><p>(8&#8211;25)</p></td><td align="left" colspan="1" rowspan="1">65.4%</td><td align="left" colspan="1" rowspan="1">22.9%</td><td align="left" colspan="1" rowspan="1">11.7%</td><td align="left" rowspan="2" colspan="1">-</td><td align="left" rowspan="2" colspan="1">87.3%</td><td align="left" rowspan="2" colspan="1">12.6%</td><td align="left" rowspan="2" colspan="1">-</td><td align="left" rowspan="2" colspan="1">0.1%</td><td align="left" rowspan="2" colspan="1">155 (120&#8211;198)</td><td align="left" rowspan="2" colspan="1">48 (37&#8211;65)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">P:0.1</italic>
</td><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">P:0.3</italic>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">P:0.004</italic></bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="4" rowspan="1">
<bold>0.002</bold>
</td><td align="left" colspan="4" rowspan="1">0.6</td><td align="left" colspan="1" rowspan="1">0.2</td><td align="left" colspan="1" rowspan="1">0.07</td></tr><tr><td align="left" rowspan="4" colspan="1">Oman</td><td align="left" colspan="1" rowspan="1"><p>Men</p><p>(132)</p></td><td align="left" colspan="1" rowspan="1"><p>6</p><p>(3&#8211;10)</p></td><td align="left" colspan="1" rowspan="1">56.1%</td><td align="left" colspan="1" rowspan="1">42.4%</td><td align="left" colspan="1" rowspan="1">0%</td><td align="left" colspan="1" rowspan="1">1.5%</td><td align="left" colspan="1" rowspan="1">68.9%</td><td align="left" colspan="1" rowspan="1">22%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">9.1%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">54 (26&#8211;66)</td></tr><tr><td align="left" rowspan="2" colspan="1"><p>Women</p><p>(58)</p></td><td align="left" rowspan="2" colspan="1"><p>8</p><p>(4&#8211;12)</p></td><td align="left" colspan="1" rowspan="1">73.7%</td><td align="left" colspan="1" rowspan="1">24.6%</td><td align="left" rowspan="2" colspan="1">0%</td><td align="left" colspan="1" rowspan="1">1.8%</td><td align="left" colspan="1" rowspan="1">49.1%</td><td align="left" colspan="1" rowspan="1">42.1%</td><td align="left" colspan="1" rowspan="1">3.5%</td><td align="left" colspan="1" rowspan="1">5.3%</td><td align="left" rowspan="2" colspan="1">-</td><td align="left" rowspan="2" colspan="1">45 (29&#8211;64)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">P:0.02</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">P:0.01</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">P:0.8</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">P:0.009</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">P:0.004</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">P:0.03</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">P:0.3</italic>
</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.1</td><td align="left" colspan="4" rowspan="1">
<bold>0.05</bold>
</td><td align="left" colspan="4" rowspan="1">
<bold>0.003</bold>
</td><td align="left" colspan="1" rowspan="1">NA</td><td align="left" colspan="1" rowspan="1">0.9</td></tr><tr><td align="left" rowspan="4" colspan="1">Poland</td><td align="left" colspan="1" rowspan="1"><p>Men</p><p>(394)</p></td><td align="left" colspan="1" rowspan="1">13 (12&#8211;13)</td><td align="left" colspan="1" rowspan="1">86.3%</td><td align="left" colspan="1" rowspan="1">13.7%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">85.8%</td><td align="left" colspan="1" rowspan="1">14%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">0.3%</td><td align="left" colspan="1" rowspan="1">150 (135&#8211;165)</td><td align="left" colspan="1" rowspan="1">45 (35&#8211;45)</td></tr><tr><td align="left" rowspan="2" colspan="1"><p>Women</p><p>(260)</p></td><td align="left" rowspan="2" colspan="1"><p>12</p><p>(8&#8211;13)</p></td><td align="left" colspan="1" rowspan="1">91.9%</td><td align="left" colspan="1" rowspan="1">7.3%</td><td align="left" colspan="1" rowspan="1">0.8%</td><td align="left" rowspan="2" colspan="1">-</td><td align="left" colspan="1" rowspan="1">62.3%</td><td align="left" colspan="1" rowspan="1">19.2%</td><td align="left" colspan="1" rowspan="1">0.4%</td><td align="left" colspan="1" rowspan="1">18.1%</td><td align="left" rowspan="2" colspan="1">125 (85&#8211;160)</td><td align="left" rowspan="2" colspan="1">35 (30&#8211;45)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">P:0.02</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">P:0.01</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">P:0.07</italic>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">P:</italic></bold>
<bold>&#8201;&lt;&#8201;</bold>
<bold><italic toggle="yes">0.0001</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">P:0.07</italic>
</td><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">P:0.2</italic>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">P:</italic></bold>
<bold>&#8201;&lt;&#8201;</bold>
<bold><italic toggle="yes">0.0001</italic></bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">
<bold>0.001</bold>
</td><td align="left" colspan="4" rowspan="1">
<bold>0.009</bold>
</td><td align="left" colspan="4" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>0.001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>0.006</bold>
</td></tr><tr><td align="left" rowspan="3" colspan="1">Romania</td><td align="left" colspan="1" rowspan="1"><p>Men</p><p>(265)</p></td><td align="left" colspan="1" rowspan="1">10 (6&#8211;16)</td><td align="left" colspan="1" rowspan="1">100%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">79.2%</td><td align="left" colspan="1" rowspan="1">20.8%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">155 (115&#8211;210)</td><td align="left" colspan="1" rowspan="1">51 (36&#8211;73)</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Women</p><p>(236)</p></td><td align="left" colspan="1" rowspan="1">11 (6&#8211;17)</td><td align="left" colspan="1" rowspan="1">100%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">74.6%</td><td align="left" colspan="1" rowspan="1">25.4%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">160 (117&#8211;214)</td><td align="left" colspan="1" rowspan="1">48 (36&#8211;68)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.3</td><td align="left" colspan="4" rowspan="1">NA</td><td align="left" colspan="4" rowspan="1">0.2</td><td align="left" colspan="1" rowspan="1">0.9</td><td align="left" colspan="1" rowspan="1">0.2</td></tr><tr><td align="left" rowspan="3" colspan="1">Spain</td><td align="left" colspan="1" rowspan="1"><p>Men</p><p>(402)</p></td><td align="left" colspan="1" rowspan="1">4 (2&#8211;8)</td><td align="left" colspan="1" rowspan="1">82.3%</td><td align="left" colspan="1" rowspan="1">17.7%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">81%</td><td align="left" colspan="1" rowspan="1">6.5%</td><td align="left" colspan="1" rowspan="1">7.7%</td><td align="left" colspan="1" rowspan="1">4.7%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Women</p><p>(244)</p></td><td align="left" colspan="1" rowspan="1">6 (2&#8211;11)</td><td align="left" colspan="1" rowspan="1">86.9%</td><td align="left" colspan="1" rowspan="1">13.1%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">77.9%</td><td align="left" colspan="1" rowspan="1">5.7%</td><td align="left" colspan="1" rowspan="1">12.3%</td><td align="left" colspan="1" rowspan="1">4.1%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.08</td><td align="left" colspan="4" rowspan="1">0.1</td><td align="left" colspan="4" rowspan="1">0.2</td><td align="left" colspan="1" rowspan="1">NA</td><td align="left" colspan="1" rowspan="1">NA</td></tr><tr><td align="left" rowspan="4" colspan="1">USA</td><td align="left" colspan="1" rowspan="1"><p>Men</p><p>(2704)</p></td><td align="left" colspan="1" rowspan="1">4 (1&#8211;11)</td><td align="left" colspan="1" rowspan="1">89.3%</td><td align="left" colspan="1" rowspan="1">8.9%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">81.4%</td><td align="left" colspan="1" rowspan="1">8.7%</td><td align="left" colspan="1" rowspan="1">8.1%</td><td align="left" colspan="1" rowspan="1">1.7%</td><td align="left" colspan="1" rowspan="1">107 (76&#8211;160)</td><td align="left" colspan="1" rowspan="1">48 (35&#8211;67)</td></tr><tr><td align="left" rowspan="2" colspan="1"><p>Women</p><p>(2440)</p></td><td align="left" rowspan="2" colspan="1">4 (1&#8211;13)</td><td align="left" colspan="1" rowspan="1">87.4%</td><td align="left" colspan="1" rowspan="1">8.6%</td><td align="left" rowspan="2" colspan="1">-</td><td align="left" rowspan="2" colspan="1">&#8211;</td><td align="left" rowspan="2" colspan="1">82.2%</td><td align="left" rowspan="2" colspan="1">8.1%</td><td align="left" rowspan="2" colspan="1">8%</td><td align="left" rowspan="2" colspan="1">1.7%</td><td align="left" rowspan="2" colspan="1">112 (80&#8211;165)</td><td align="left" rowspan="2" colspan="1">48 (38&#8211;71)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">P:0.03</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">P:0.7</italic>
</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">
<bold>0.03</bold>
</td><td align="left" colspan="4" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="4" rowspan="1">0.8</td><td align="left" colspan="1" rowspan="1">0.3</td><td align="left" colspan="1" rowspan="1">0.3</td></tr><tr><td align="left" rowspan="3" colspan="1">Turkey</td><td align="left" colspan="1" rowspan="1"><p>Men</p><p>(283)</p></td><td align="left" colspan="1" rowspan="1">4 (2&#8211;12)</td><td align="left" colspan="1" rowspan="1">100%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">72.8%</td><td align="left" colspan="1" rowspan="1">14.1%</td><td align="left" colspan="1" rowspan="1">8.1%</td><td align="left" colspan="1" rowspan="1">4.9%</td><td align="left" colspan="1" rowspan="1">140 (100&#8211;221)</td><td align="left" colspan="1" rowspan="1">54 (44&#8211;68)</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Women</p><p>(217)</p></td><td align="left" colspan="1" rowspan="1">6 (2&#8211;15)</td><td align="left" colspan="1" rowspan="1">100%</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">72.8%</td><td align="left" colspan="1" rowspan="1">17.1%</td><td align="left" colspan="1" rowspan="1">7.8%</td><td align="left" colspan="1" rowspan="1">2.3%</td><td align="left" colspan="1" rowspan="1">135 (110&#8211;192)</td><td align="left" colspan="1" rowspan="1">57 (43&#8211;81)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.08</td><td align="left" colspan="4" rowspan="1">NA</td><td align="left" colspan="4" rowspan="1">0.4</td><td align="left" colspan="1" rowspan="1">0.7</td><td align="left" colspan="1" rowspan="1">0.5</td></tr><tr><td align="left" rowspan="3" colspan="1">Paraguay</td><td align="left" colspan="1" rowspan="1"><p>Men</p><p>(258)</p></td><td align="left" colspan="1" rowspan="1">6 (3&#8211;10)</td><td align="left" colspan="1" rowspan="1">86.4%</td><td align="left" colspan="1" rowspan="1">12.1%</td><td align="left" colspan="1" rowspan="1">1.6%</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">88.5%</td><td align="left" colspan="1" rowspan="1">11.5%</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">180 (195&#8211;195)</td><td align="left" colspan="1" rowspan="1">60 (45&#8211;65)</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>Women</p><p>(161)</p></td><td align="left" colspan="1" rowspan="1">8.5 (4&#8211;12)</td><td align="left" colspan="1" rowspan="1">89.4%</td><td align="left" colspan="1" rowspan="1">8.1%</td><td align="left" colspan="1" rowspan="1">2.5%</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">86.1%</td><td align="left" colspan="1" rowspan="1">13.9%</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">163 (100&#8211;190)</td><td align="left" colspan="1" rowspan="1">65 (41&#8211;93)</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">
<bold>0.01</bold>
</td><td align="left" colspan="4" rowspan="1">0.3</td><td align="left" colspan="4" rowspan="1">0.5</td><td align="left" colspan="1" rowspan="1">0.18</td><td align="left" colspan="1" rowspan="1">0.3</td></tr></tbody></table><table-wrap-foot><p>*Median (IQR), <italic toggle="yes">TIA</italic> transient ischemic attacks, <italic toggle="yes">IVT</italic> intravenous thrombolysis, <italic toggle="yes">MT</italic> mechanical thrombectomy</p><p>Bold values refer to statistically significant variables</p></table-wrap-foot></table-wrap><table-wrap id="Tab5" position="float" orientation="portrait"><label>Table 5</label><caption><p>Stroke outcome in relation to sex among the participating countries</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Sex No</th><th align="left" colspan="1" rowspan="1">mRS discharge</th><th align="left" colspan="1" rowspan="1">mRS 3&#160;months</th></tr></thead><tbody><tr><td align="left" rowspan="3" colspan="1">Egypt</td><td align="left" colspan="1" rowspan="1">Men (2807)</td><td align="left" colspan="1" rowspan="1">42.4%</td><td align="left" colspan="1" rowspan="1">54.1%</td></tr><tr><td align="left" colspan="1" rowspan="1">Women (1813)</td><td align="left" colspan="1" rowspan="1">35.2%</td><td align="left" colspan="1" rowspan="1">47.3%</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">
<bold>0.001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" rowspan="3" colspan="1">Iran</td><td align="left" colspan="1" rowspan="1">Men (3192)</td><td align="left" colspan="1" rowspan="1">22.2%</td><td align="left" colspan="1" rowspan="1">29.6%</td></tr><tr><td align="left" colspan="1" rowspan="1">Women (2793)</td><td align="left" colspan="1" rowspan="1">17.4%</td><td align="left" colspan="1" rowspan="1">24.3%</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" rowspan="3" colspan="1">Oman</td><td align="left" colspan="1" rowspan="1">Men (132)</td><td align="left" colspan="1" rowspan="1">NA</td><td align="left" colspan="1" rowspan="1">35.2%</td></tr><tr><td align="left" colspan="1" rowspan="1">Women (58)</td><td align="left" colspan="1" rowspan="1">NA</td><td align="left" colspan="1" rowspan="1">34.8%</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">NA</td><td align="left" colspan="1" rowspan="1">0.97</td></tr><tr><td align="left" rowspan="3" colspan="1">Poland</td><td align="left" colspan="1" rowspan="1">Men (394)</td><td align="left" colspan="1" rowspan="1">16.1%</td><td align="left" colspan="1" rowspan="1">17.4%</td></tr><tr><td align="left" colspan="1" rowspan="1">Women (260)</td><td align="left" colspan="1" rowspan="1">47.7%</td><td align="left" colspan="1" rowspan="1">52.8%</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" rowspan="3" colspan="1">Romania</td><td align="left" colspan="1" rowspan="1">Men (265)</td><td align="left" colspan="1" rowspan="1">46%</td><td align="left" colspan="1" rowspan="1">56.1%</td></tr><tr><td align="left" colspan="1" rowspan="1">Women (236)</td><td align="left" colspan="1" rowspan="1">39%</td><td align="left" colspan="1" rowspan="1">48.8%</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">0.11</td><td align="left" colspan="1" rowspan="1">0.3</td></tr><tr><td align="left" rowspan="3" colspan="1">Spain</td><td align="left" colspan="1" rowspan="1">Men (402)</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">46.2%</td></tr><tr><td align="left" colspan="1" rowspan="1">Women (244)</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">34.1%</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">0.05</td></tr><tr><td align="left" rowspan="3" colspan="1">USA</td><td align="left" colspan="1" rowspan="1">Men (2704)</td><td align="left" colspan="1" rowspan="1">27.7%</td><td align="left" colspan="1" rowspan="1">34.2%</td></tr><tr><td align="left" colspan="1" rowspan="1">Women (2440)</td><td align="left" colspan="1" rowspan="1">23.8%</td><td align="left" colspan="1" rowspan="1">29.9%</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">
<bold>0.007</bold>
</td><td align="left" colspan="1" rowspan="1">0.1</td></tr><tr><td align="left" rowspan="3" colspan="1">Turkey</td><td align="left" colspan="1" rowspan="1">Men (283)</td><td align="left" colspan="1" rowspan="1">46.3%</td><td align="left" colspan="1" rowspan="1">60.3%</td></tr><tr><td align="left" colspan="1" rowspan="1">Women (217)</td><td align="left" colspan="1" rowspan="1">31.3%</td><td align="left" colspan="1" rowspan="1">44%</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">
<bold>0.001</bold>
</td><td align="left" colspan="1" rowspan="1">
<bold>&#8201;&lt;&#8201;0.0001</bold>
</td></tr><tr><td align="left" rowspan="3" colspan="1">Paraguay</td><td align="left" colspan="1" rowspan="1">Men (258)</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1">Women (161)</td><td align="left" colspan="1" rowspan="1">-</td><td align="left" colspan="1" rowspan="1">-</td></tr><tr><td align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic>-value</td><td align="left" colspan="1" rowspan="1">NA</td><td align="left" colspan="1" rowspan="1">NA</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">mRS</italic> Modified Rankin Scale favorable outcome: (&lt;&#8201;2)</p><p>Bold values refer to statistically significant variables</p></table-wrap-foot></table-wrap></sec></sec><sec id="Sec12"><title>Severity</title><p id="Par31">NIHSS was higher in women in all countries except Poland, where men had a severer stroke. Egypt, Iran, the USA, and Paraguay had significantly more severe strokes in women than in other countries.</p></sec><sec id="Sec13"><title>Type of stroke</title><p id="Par32">Incidence of ischemic stroke was significantly more in women in Oman and Poland, while it was more in men in the USA. Hemorrhagic stroke was significantly more in men in Oman and Poland.</p><p id="Par33">TIA was more in women in Iran. Moreover, in Egypt and Oman, subarachnoid hemorrhage was similar in both sexes, while other countries did not report it.</p><p id="Par34">As for acute management, in Egypt, only bridging therapy was significantly more often in women; in Oman IVT and MT were more in women, while conservative therapy was more in men so was bridging therapy. Poland reported IVT and bridging more in women, while conservative therapy was more frequently given to men.</p><p id="Par35">Outcome was worse among women in all countries except Poland. This sex difference was significant in Egypt, Iran, USA, and Turkey.</p></sec><sec id="Sec14"><title>Discussion</title><p id="Par36">The study of sex differences is an emerging field of stroke epidemiology and care. This study explored sex differences related to various aspects of stroke etiology and management.</p><sec id="Sec15"><title>Comparison between sexes in the whole sample</title><p id="Par37">Among the studied cohort of 18,659 patients, stroke incidence was higher among men with a ratio of 1.27:1. And despite that the ratio might vary among studies, yet the incidence is consistently higher among men. Generally speaking, women reportedly have a lower risk of developing stroke than men, though the magnitude of this difference decreases after menopause [<xref ref-type="bibr" rid="CR8">8</xref>]. In line with this, most of the participating countries reported that age-related difference was reversed for those aged above 60.</p><p id="Par38">Similar to previously published studies, the mean age at stroke presentation was higher among women [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. On average, women were about 4&#160;years older than men, which is concordant with other research that has also demonstrated that women were older at the time of their first stroke [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par39">Regarding the mean age of the whole patients (males and females), we noticed that Egyptian stroke patients were younger than stroke patients in other countries. It is noticeable in most studies from Egypt that the age of stroke patients is younger than other countries. This is possibly either due to multiple risk factors or is genetically determined. The mean age is around 62 in several of our previous research [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par40">Regarding risk factor profile according to sex, our findings coincide with other studies [<xref ref-type="bibr" rid="CR15">15</xref>&#8211;<xref ref-type="bibr" rid="CR18">18</xref>]. Most important to mention is AF that is consistently relevant to sex so female sex has been incorporated as a risk factor in the CHADS2VASc2 score for decision-making about anticoagulation [<xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par41">There was a disparity between our findings and other studies reporting higher prevalence of dyslipidaemia in women [<xref ref-type="bibr" rid="CR20">20</xref>]. The prevalence of dyslipidaemia was reportedly associated with higher socioeconomic development and is attributable to western diet and high caloric intake [<xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par42">Thus, this low prevalence of dyslipidaemia in our sample could be due to racial differences or dietary habits, given the preponderance of eastern population reaching 61% among our cohort.</p><p id="Par43">On comparison of stroke subtypes, although we found variable patterns between both sexes, yet others reported that with the exception of SAH, there is little evidence of sex difference in stroke subtypes [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par44">Regarding stroke severity and outcome, we found that women had a severer stroke on admission and worse outcome which could be attributed to their older age at the time of stroke incidence. However even after adjusting for age, still female sex per se was found to be a determinant for negative outcome [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. In addition, the poor outcome in women has been ascribed to lower pre-stroke functional status, body mass index, AF, and hypertension [<xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par45">But despite this sex difference in outcome, our results illustrated that the type of management was similar for sexes except for bridging therapy that was more frequently administered in women. Pre-hospital delay was significantly lower among women, while other in-hospital time factors showed no difference. Many previous western studies reported that OTD is longer in women. We suppose that this trend might have changed in the past few years, that is why the title of our article is &#8220;Do stroke services still show sex differences? A multicentre study.&#8221; We have 2 comments here. First that the bigger number of patients in our study (11,295) is from eastern countries versus (7364) from western countries. Thus, the results might be colored by the eastern culture where elderly women are usually living with caregivers from the family, and any health issue is promptly attended to by family members. This cultural notion was highlighted in a recent reference stating &#8220;women are less likely to receive IVT compared to men in the US and most European countries, but not in Asia and Germany.&#8221; [<xref ref-type="bibr" rid="CR26">26</xref>] Second, the trends might be changing due to public awareness of stroke and urgency of early treatment; thus, the gap between sexes is diminishing. This has been mentioned in the same study as the one cited below where they stated &#8220;Subgroup analyses including only patients deemed eligible for IVT however did not show any significant sex difference in IVT treatment anymore.&#8221; [<xref ref-type="bibr" rid="CR26">26</xref>].</p><p id="Par46">The sex difference in revascularization therapy varied among various studies. It was previously observed in European and US-based studies but not in studies from Asia and Germany [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR27">27</xref>].</p></sec><sec id="Sec16"><title>Comparison between age groups among women</title><p id="Par47">Concerning stroke subtype, similar to other studies, the presence of cardio-embolic stroke in older patients is explained by higher prevalence of AF [<xref ref-type="bibr" rid="CR28">28</xref>]. On the other hand, the absence of conventional risk factors explains why younger age group presented with stroke of undetermined/other determined etiology [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>].</p><p id="Par48">When it comes to severity and outcome, the presence of comorbidities and premorbid state related to aging, in addition to the higher incidence of cardio-embolic stroke, could explain severer stroke in advanced age [<xref ref-type="bibr" rid="CR31">31</xref>].</p></sec><sec id="Sec17"><title>Comparison of stroke characteristics across participating countries</title><p id="Par49">The median age of women in both Egypt and Oman was younger as compared to all other countries, and this comes in the context of a younger age of stroke for the whole population [<xref ref-type="bibr" rid="CR23">23</xref>].</p><p id="Par50">The younger age of stroke patients in Egypt and Oman compared to other countries, and on the contrary the very few young patients in Poland, both need further verification by future research.</p><p id="Par51">Also, Poland was the only country to have less stroke severity and better outcome among women, possibly because women had significantly less prevalence of hypertension and less hemorrhagic strokes than men. Moreover, women who had an ischemic stroke were more prone to receive IVT and bridging therapy.</p><p id="Par52">Similar to a previous study [<xref ref-type="bibr" rid="CR15">15</xref>], there was a trend towards administering interventional management to women that reached a significantly higher level than men in some countries. The shorter onset to door reported for women could be a contributing factor for the type of management.</p><p id="Par53">We can conclude that globally, stroke services provided to women are no more inferior to those provided to men, thanks to previous work that drew attention to this sex disparity. Despite that, still female sex remains an unmodifiable risk factor for severer stroke and worse outcome. Thus, future studies are warranted to explore modifiable female-related risk factors including pregnancy, postpartum, and hormonal changes [<xref ref-type="bibr" rid="CR8">8</xref>].</p></sec></sec><sec id="Sec18"><title>Study limitations</title><p id="Par54">In the current study, all patients were recruited from specialized stroke units where the best acute stroke services are supposedly offered. So, the results do not reflect the state of services in general hospitals in the participating countries.</p></sec></body><back><fn-group><fn><p>
<bold>What</bold>
<bold> is already known on this topic</bold>
</p><p>&#8226; The burden of stroke is increasing worldwide.</p><p>&#8226; A poor understanding of sex differences leads to misconceptions and biases in the management of male and female stroke patients.</p><p>
<bold>What this study adds</bold>
</p><p>&#8226; Explore sex difference in stroke services in different countries.</p><p>How this study might affect research, practice, or policy.</p><p>&#8226; Improve the quality of stroke services provided to patients.</p></fn><fn><p><bold>Publisher's note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="funding-information"><title>Funding</title><p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par55">The authors declare no competing interests.</p></notes><notes id="FPar2"><title>Ethical approval</title><p id="Par56">Each group of authors from each center receives IRB from their local ethical committee.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>Q</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Yao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Cai</surname><given-names>T</given-names></name><name name-style="western"><surname>Han</surname><given-names>L</given-names></name></person-group><article-title>Global, regional, and national burden of ischemic stroke, 1990&#8217;2019</article-title><source>Neurology</source><year>2022</year><volume>98</volume><issue>3</issue><fpage>E279</fpage><lpage>E290</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000013115</pub-id><pub-id pub-id-type="pmid">34911748</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>The Lancet Neurology</collab></person-group><article-title>A spotlight on sex differences in neurological disorders</article-title><source>Lancet Neurol</source><year>2019</year><volume>18</volume><issue>4</issue><fpage>319</fpage><pub-id pub-id-type="doi">10.1016/S1474-4422(19)30001-8</pub-id><pub-id pub-id-type="pmid">30878094</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weber</surname><given-names>R</given-names></name><name name-style="western"><surname>Krogias</surname><given-names>C</given-names></name><name name-style="western"><surname>Eyding</surname><given-names>J</given-names></name><etal/></person-group><article-title>Age and sex differences in ischemic stroke treatment in a nationwide analysis of 1.11 million hospitalized cases</article-title><source>Stroke</source><year>2019</year><volume>50</volume><issue>12</issue><fpage>3494</fpage><lpage>3502</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.119.026723</pub-id><pub-id pub-id-type="pmid">31623547</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ayala</surname><given-names>C</given-names></name><name name-style="western"><surname>Croft</surname><given-names>JB</given-names></name><name name-style="western"><surname>Greenlund</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>Sex differences in US mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995&#8211;1998</article-title><source>Stroke</source><year>2002</year><volume>33</volume><issue>5</issue><fpage>1197</fpage><lpage>1201</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000015028.52771.D1</pub-id><pub-id pub-id-type="pmid">11988590</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Women&#8217;s Health (1985) Report of the public health service task force on women&#8217;s health issues. Publ Health Rep 100(1):73&#8211;106<pub-id pub-id-type="pmcid">PMC1424718</pub-id><pub-id pub-id-type="pmid">3918328</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jaberinezhad</surname><given-names>M</given-names></name><name name-style="western"><surname>Farhoudi</surname><given-names>M</given-names></name><name name-style="western"><surname>Nejadghaderi</surname><given-names>SA</given-names></name><etal/></person-group><article-title>The burden of stroke and its attributable risk factors in the Middle East and North Africa region, 1990&#8211;2019</article-title><source>Sci Rep</source><year>2022</year><volume>12</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/s41598-022-06418-x</pub-id><pub-id pub-id-type="pmid">35177688</pub-id><pub-id pub-id-type="pmcid">PMC8854638</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nogueira</surname><given-names>RG</given-names></name><name name-style="western"><surname>Qureshi</surname><given-names>MM</given-names></name><name name-style="western"><surname>Abdalkader</surname><given-names>M</given-names></name><etal/></person-group><article-title>Global impact of COVID-19 on stroke care and IV thrombolysis</article-title><source>Neurology</source><year>2021</year><volume>96</volume><issue>23</issue><fpage>e2824</fpage><lpage>e2838</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000011885</pub-id><pub-id pub-id-type="pmid">33766997</pub-id><pub-id pub-id-type="pmcid">PMC8205458</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">Kremer C, Gdovinova Z, Bejot Y et al (2022) European Stroke Organisation guidelines on stroke in women: management of menopause, pregnancy and postpartum. Eur Stroke J 7(2):I-XIX. 10.1177/23969873221078696<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/23969873221078696</pub-id><pub-id pub-id-type="pmcid">PMC9134774</pub-id><pub-id pub-id-type="pmid">35647308</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCullough</surname><given-names>LD</given-names></name><name name-style="western"><surname>Alkayed</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Traystman</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Williams</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Hurn</surname><given-names>PD</given-names></name></person-group><article-title>Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke</article-title><source>Stroke</source><year>2001</year><volume>32</volume><issue>3</issue><fpage>796</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1161/01.STR.32.3.796</pub-id><pub-id pub-id-type="pmid">11239204</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>SJ</given-names></name><name name-style="western"><surname>McCullough</surname><given-names>LD</given-names></name><name name-style="western"><surname>Smith</surname><given-names>JM</given-names></name></person-group><article-title>Stroke in the female: role of biological sex and estrogen</article-title><source>ILAR J</source><year>2004</year><volume>45</volume><issue>2</issue><fpage>147</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.1093/ilar.45.2.147</pub-id><pub-id pub-id-type="pmid">15111734</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Danesi</surname><given-names>MA</given-names></name><name name-style="western"><surname>Okubadejo</surname><given-names>NU</given-names></name><name name-style="western"><surname>Ojini</surname><given-names>FI</given-names></name><name name-style="western"><surname>Ojo</surname><given-names>OO</given-names></name></person-group><article-title>Incidence and 30-day case fatality rate of first-ever stroke in urban Nigeria: the prospective community based Epidemiology of Stroke in Lagos (EPISIL) phase II results</article-title><source>J Neurol Sci</source><year>2013</year><volume>331</volume><issue>1&#8211;2</issue><fpage>43</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.jns.2013.04.026</pub-id><pub-id pub-id-type="pmid">23726277</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Appelros</surname><given-names>P</given-names></name><name name-style="western"><surname>Stegmayr</surname><given-names>B</given-names></name><name name-style="western"><surname>Ter&#233;nt</surname><given-names>A</given-names></name></person-group><article-title>Sex differences in stroke epidemiology</article-title><source>Stroke</source><year>2009</year><volume>40</volume><issue>4</issue><fpage>1082</fpage><lpage>1090</lpage><pub-id pub-id-type="doi">10.1161/strokeaha.108.540781</pub-id><pub-id pub-id-type="pmid">19211488</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farag</surname><given-names>S</given-names></name><name name-style="western"><surname>Kenawy</surname><given-names>FF</given-names></name><name name-style="western"><surname>Shokri</surname><given-names>HM</given-names></name><etal/></person-group><article-title>The clinical characteristics of patients with pre-existing leukoaraiosis compared to those without leukoaraiosis in acute ischemic stroke</article-title><source>J Stroke Cerebrovasc Dis</source><year>2021</year><volume>30</volume><issue>9</issue><fpage>105956</fpage><pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2021.105956</pub-id><pub-id pub-id-type="pmid">34217070</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El Nahas</surname><given-names>NM</given-names></name><name name-style="western"><surname>Shokri</surname><given-names>HM</given-names></name><name name-style="western"><surname>Roushdy</surname><given-names>TM</given-names></name><etal/></person-group><article-title>Urban versus rural Egypt: stroke risk factors and clinical profile: cross-sectional observational study</article-title><source>J Stroke Cerebrovasc Dis</source><year>2019</year><volume>28</volume><issue>11</issue><fpage>104316</fpage><pub-id pub-id-type="doi">10.1016/j.jstrokecerebrovasdis.2019.104316</pub-id><pub-id pub-id-type="pmid">31416762</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Madsen TE, Khoury JC, Leppert M et al. Temporal trends in stroke incidence over time by sex and age in the GCNKSS. Stroke. Published online 2020:1070&#8211;1076. 10.1161/STROKEAHA.120.028910<pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.120.028910</pub-id><pub-id pub-id-type="pmcid">PMC7286565</pub-id><pub-id pub-id-type="pmid">32078459</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rexrode</surname><given-names>KM</given-names></name><name name-style="western"><surname>Madsen</surname><given-names>TE</given-names></name><name name-style="western"><surname>Yu</surname><given-names>AYX</given-names></name><name name-style="western"><surname>Carcel</surname><given-names>C</given-names></name><name name-style="western"><surname>Lichtman</surname><given-names>JH</given-names></name><name name-style="western"><surname>Miller</surname><given-names>EC</given-names></name></person-group><article-title>The impact of sex and gender on stroke</article-title><source>Circ Res</source><year>2022</year><volume>130</volume><issue>4</issue><fpage>512</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.121.319915</pub-id><pub-id pub-id-type="pmid">35175851</pub-id><pub-id pub-id-type="pmcid">PMC8890686</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>SAE</given-names></name><name name-style="western"><surname>Carcel</surname><given-names>C</given-names></name><name name-style="western"><surname>Millett</surname><given-names>ERC</given-names></name><name name-style="western"><surname>Woodward</surname><given-names>M</given-names></name></person-group><article-title>Sex differences in the association between major risk factors and the risk of stroke in the UK Biobank cohort study</article-title><source>Neurology</source><year>2020</year><volume>95</volume><issue>20</issue><fpage>E2715</fpage><lpage>E2726</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000010982</pub-id><pub-id pub-id-type="pmid">33067404</pub-id><pub-id pub-id-type="pmcid">PMC7734722</pub-id></element-citation></ref><ref id="CR18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>SAE</given-names></name><name name-style="western"><surname>Huxley</surname><given-names>RR</given-names></name><name name-style="western"><surname>Woodward</surname><given-names>M</given-names></name></person-group><article-title>Comparison of the sex-specific associations between systolic blood pressure and the risk of cardiovascular disease: a systematic review and meta-analysis of 124 cohort studies, including 1.2 million individuals</article-title><source>Stroke</source><year>2013</year><volume>44</volume><issue>9</issue><fpage>2394</fpage><lpage>2401</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.113.001624</pub-id><pub-id pub-id-type="pmid">23821229</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madsen</surname><given-names>TE</given-names></name><name name-style="western"><surname>Howard</surname><given-names>G</given-names></name><name name-style="western"><surname>Kleindorfer</surname><given-names>DO</given-names></name><etal/></person-group><article-title>Sex differences in hypertension and stroke risk in the REGARDS study: a longitudinal cohort study</article-title><source>Hypertension</source><year>2019</year><volume>74</volume><issue>4</issue><fpage>749</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.119.12729</pub-id><pub-id pub-id-type="pmid">31405299</pub-id><pub-id pub-id-type="pmcid">PMC6741430</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madsen</surname><given-names>TE</given-names></name><name name-style="western"><surname>Howard</surname><given-names>VJ</given-names></name><name name-style="western"><surname>Jim&#233;nez</surname><given-names>M</given-names></name><etal/></person-group><article-title>Impact of conventional stroke risk factors on stroke in women an update</article-title><source>Stroke</source><year>2018</year><volume>49</volume><issue>3</issue><fpage>536</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.117.018418</pub-id><pub-id pub-id-type="pmid">29438086</pub-id><pub-id pub-id-type="pmcid">PMC5828997</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pirillo</surname><given-names>A</given-names></name><name name-style="western"><surname>Casula</surname><given-names>M</given-names></name><name name-style="western"><surname>Olmastroni</surname><given-names>E</given-names></name><name name-style="western"><surname>Norata</surname><given-names>GD</given-names></name><name name-style="western"><surname>Catapano</surname><given-names>AL</given-names></name></person-group><article-title>Global epidemiology of dyslipidaemias</article-title><source>Nat Rev Cardiol</source><year>2021</year><volume>18</volume><issue>10</issue><fpage>689</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1038/s41569-021-00541-4</pub-id><pub-id pub-id-type="pmid">33833450</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kapral</surname><given-names>MK</given-names></name><name name-style="western"><surname>Fang</surname><given-names>J</given-names></name><name name-style="western"><surname>Hill</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network</article-title><source>Stroke</source><year>2005</year><volume>36</volume><issue>4</issue><fpage>809</fpage><lpage>814</lpage><pub-id pub-id-type="doi">10.1161/01.STR.0000157662.09551.e5</pub-id><pub-id pub-id-type="pmid">15731476</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reeves</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Bushnell</surname><given-names>CD</given-names></name><name name-style="western"><surname>Howard</surname><given-names>G</given-names></name><etal/></person-group><article-title>Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes</article-title><source>Lancet Neurol</source><year>2008</year><volume>7</volume><issue>10</issue><fpage>915</fpage><lpage>926</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(08)70193-5</pub-id><pub-id pub-id-type="pmid">18722812</pub-id><pub-id pub-id-type="pmcid">PMC2665267</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>B</given-names></name><name name-style="western"><surname>De</surname><given-names>LS</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>ZQ</given-names></name><name name-style="western"><surname>Peng</surname><given-names>B</given-names></name></person-group><article-title>Sex differences of acute stroke treatment and in hospital outcomes after intravenous thrombolysis in patients with ischemic stroke</article-title><source>Front Neurol</source><year>2020</year><volume>11</volume><issue>October</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.3389/fneur.2020.545860</pub-id><pub-id pub-id-type="pmid">33133001</pub-id><pub-id pub-id-type="pmcid">PMC7578410</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">Bonkhoff AK, Karch A, Weber R, Wellmann J, Berger K (2021) Female stroke: sex differences in acute treatment and early outcomes of acute ischemic stroke. Stroke (February):406&#8211;415. 10.1161/STROKEAHA.120.032850<pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.120.032850</pub-id><pub-id pub-id-type="pmid">33493053</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ospel</surname><given-names>J</given-names></name><name name-style="western"><surname>Singh</surname><given-names>N</given-names></name><name name-style="western"><surname>Ganesh</surname><given-names>A</given-names></name><name name-style="western"><surname>Goyal</surname><given-names>M</given-names></name></person-group><article-title>Sex and gender differences in stroke and their practical implications in acute care</article-title><source>J Stroke</source><year>2023</year><volume>25</volume><issue>1</issue><fpage>16</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.5853/jos.2022.04077</pub-id><pub-id pub-id-type="pmid">36746379</pub-id><pub-id pub-id-type="pmcid">PMC9911850</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phan</surname><given-names>HT</given-names></name><name name-style="western"><surname>Blizzard</surname><given-names>CL</given-names></name><name name-style="western"><surname>Reeves</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Sex differences in long-term mortality after stroke in INSTRUCT (INternational STRoke oUtComes sTudy)</article-title><source>Circ Cardiovasc Qual Outcomes</source><year>2017</year><volume>10</volume><issue>2</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.116.003436</pub-id><pub-id pub-id-type="pmid">28228454</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strong</surname><given-names>B</given-names></name><name name-style="western"><surname>Lisabeth</surname><given-names>LD</given-names></name><name name-style="western"><surname>Reeves</surname><given-names>M</given-names></name></person-group><article-title>Sex differences in IV thrombolysis treatment for acute ischemic stroke: a systematic review and meta-analysis</article-title><source>Neurology</source><year>2020</year><volume>95</volume><issue>1</issue><fpage>11</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000009733</pub-id><pub-id pub-id-type="pmid">32522796</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heidenreich</surname><given-names>PA</given-names></name><name name-style="western"><surname>Trogdon</surname><given-names>JG</given-names></name><name name-style="western"><surname>Khavjou</surname><given-names>OA</given-names></name><etal/></person-group><article-title>Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association</article-title><source>Circulation</source><year>2011</year><volume>123</volume><issue>8</issue><fpage>933</fpage><lpage>944</lpage><pub-id pub-id-type="doi">10.1161/CIR.0b013e31820a55f5</pub-id><pub-id pub-id-type="pmid">21262990</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smajlovi&#263;</surname><given-names>D</given-names></name></person-group><article-title>Strokes in young adults: epidemiology and prevention</article-title><source>Vasc Health Risk Manag</source><year>2015</year><volume>11</volume><fpage>157</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.2147/VHRM.S53203</pub-id><pub-id pub-id-type="pmid">25750539</pub-id><pub-id pub-id-type="pmcid">PMC4348138</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="other">Si Y, Xiang S, Zhang Y et al (2020) Clinical profile of aetiological and risk factors of young adults with ischemic stroke in West China. Clin Neurol Neurosurg 193(August 2019):105753. 10.1016/j.clineuro.2020.105753<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clineuro.2020.105753</pub-id><pub-id pub-id-type="pmid">32126283</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>